Guangdong Zhongsheng Pharmaceutical Hits Day High with 10.02% Surge

Guangdong Zhongsheng Pharmaceutical Co., Ltd. has experienced a significant surge in its stock performance, gaining 10.02% on July 10, 2026. The stock reached an intraday high of CNY 29.54, showcasing its strong market activity. This performance stands in stark contrast to the China Shanghai Composite, which declined by 1.0% on the same day. Over the past month, Guangdong Zhongsheng has demonstrated impressive growth, with a 34.21% increase, while the broader market has remained relatively flat, posting a mere 0.07% gain. The company's year-to-date performance is also noteworthy, with a 55.64% rise compared to the China Shanghai Composite's modest 0.69% increase. Financially, Guangdong Zhongsheng has shown resilience, reporting a net profit of CNY 148.42 million in its latest half-year results and achieving a record operating cash flow of CNY 497.18 million. The company has consistently delivered positive results over the last four quarters, contributing to its robust performance metrics. With a market capitalization of CNY 15,764 million, Guangdong Zhongsheng continues to position itself strongly within the pharmaceuticals and biotechnology sector.